Tuesday, March 31, 2015 10:53:30 AM
Sorry I don't bother to pay because I like to keep my conversations in the open. I disagree with you, I don't see this company being the same as those other two but that's why we all have opinions. I would've never even looked at the other two. I guess you're out if you're saying best of luck 
I see something very unique, I see an emerging biotech company with possible current revenue, if the cards are played right which almost no biotech company has (revenue possibilities), a worldwide market that's going to expand faster than we can imagine. These are solid people they are not leaving the game. If the stock hit $.10 I would buy more
There been no "illegal" information given to me I promise you that. LOL.
It's public knowledge that Paul is not with the company. Some people just aren't accepting it. Go to the website
As far as I understand illegal is telling somebody to do something based on what's going to happen in the future. Talking about a company is perfectly legal as long as you do not reveal your future moves for the sake of somebody's gain.
I see something very unique, I see an emerging biotech company with possible current revenue, if the cards are played right which almost no biotech company has (revenue possibilities), a worldwide market that's going to expand faster than we can imagine. These are solid people they are not leaving the game. If the stock hit $.10 I would buy more
There been no "illegal" information given to me I promise you that. LOL.
It's public knowledge that Paul is not with the company. Some people just aren't accepting it. Go to the website
As far as I understand illegal is telling somebody to do something based on what's going to happen in the future. Talking about a company is perfectly legal as long as you do not reveal your future moves for the sake of somebody's gain.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
